Author Villar-Piqué, Anna

• 2018 | Journal Article
  ​ ​Cerebrospinal Fluid Total Prion Protein in the Spectrum of Prion Diseases​
  Villar-Piqué, A.; Schmitz, M.; Lachmann, I.; Karch, A.; Calero, O.; Stehmann, C. & Sarros, S. et al.​ (2018) 
  Molecular Neurobiology, 56(4) pp. 2811​-2821​.​ DOI: https://doi.org/10.1007/s12035-018-1251-1 
  ​Details  DOI 

• 2018 | Journal Article
  ​ ​Cerebrospinal Fluid Prion Disease Biomarkers in Pre-clinical and Clinical Naturally Occurring Scrapie​
  Llorens, F.; Barrio, T.; Correia, Â.; Villar-Piqué, A.; Thüne, K.; Lange, P. & Badiola, J. J. et al.​ (2018) 
  Molecular Neurobiology, 55(11) pp. 8586​-8591​.​ DOI: https://doi.org/10.1007/s12035-018-1014-z 
  ​Details  DOI 

• 2018 | Journal Article | 
  ​ ​Interlaboratory validation of cerebrospinal fluid α-synuclein quantification in the diagnosis of sporadic Creutzfeldt-Jakob disease​
  Kruse, N.; Heslegrave, A.; Gupta, V.; Foiani, M.; Villar-Piqué, A.; Schmitz, M. & Lehmann, S. et al.​ (2018) 
  Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 10 pp. 461​-470​.​ DOI: https://doi.org/10.1016/j.dadm.2018.06.005 
  ​Details  DOI  PMID  PMC 

• 2019 | Journal Article
  ​ ​Cerebrospinal fluid neurofilament light in suspected sporadic Creutzfeldt-Jakob disease​
  Kanata, E.; Golanska, E.; Villar-Piqué, A.; Karsanidou, A.; Dafou, D.; Xanthopoulos, K. & Schmitz, M. et al.​ (2019) 
  Journal of Clinical Neuroscience, 60 pp. 124​-127​.​ DOI: https://doi.org/10.1016/j.jocn.2018.09.031 
  ​Details  DOI 

• 2019 | Journal Article
  ​ ​Cerebrospinal fluid non-phosphorylated tau in the differential diagnosis of Creutzfeldt–Jakob disease: a comparative prospective study with 14-3-3​
  Llorens, F.; Villar-Piqué, A.; Hermann, P.; Schmitz, M.; Goebel, S.; Waniek, K. & Lachmann, I. et al.​ (2019) 
  Journal of Neurology, 267(2) pp. 543​-550​.​ DOI: https://doi.org/10.1007/s00415-019-09610-8 
  ​Details  DOI 

• 2019 | Journal Article | Research Paper
  ​ ​Nuclear localization and phosphorylation modulate pathological effects of alpha-synuclein​
  Pinho, R.; Paiva, I.; Jercic, K. G.; Fonseca-Ornelas, L.; Gerhardt, E.; Fahlbusch, C. & Garcia-Esparcia, P. et al.​ (2019) 
  Human Molecular Genetics, 28(1) pp. 31​-50​.​ DOI: https://doi.org/10.1093/hmg/ddy326 
  ​Details  DOI  PMID  PMC 

• 2019 | Journal Article | Research Paper | 
  ​ ​Cytosolic Trapping of a Mitochondrial Heat Shock Protein Is an Early Pathological Event in Synucleinopathies​
  Szegő, É. M.; Dominguez-Meijide, A.; Gerhardt, E.; König, A.; Koss, D. J.; Li, W. & Pinho, R. et al.​ (2019) 
  Cell Reports, 28(1) pp. 65.e6​-77.e6​.​ DOI: https://doi.org/10.1016/j.celrep.2019.06.009 
  ​Details  DOI  PMID  PMC 

• 2020 | Journal Article
  ​ ​A new tetra-plex fluorimetric assay for the quantification of cerebrospinal fluid β-amyloid42, total-tau, phospho-tau and α-synuclein in the differential diagnosis of neurodegenerative dementia​
  Diaz-Lucena, D.; Escaramis, G.; Villar-Piqué, A.; Hermann, P.; Schmitz, M.; Varges, D. & Santana, I. et al.​ (2020) 
  Journal of Neurology, 267(9) pp. 2567​-2581​.​ DOI: https://doi.org/10.1007/s00415-020-09870-9 
  ​Details  DOI 

• 2021 | Journal Article | Research Paper | 
  ​ ​Detection of Cerebrospinal Fluid Neurofilament Light Chain as a Marker for Alpha-Synucleinopathies​
  Canaslan, S.; Schmitz, M.; Villar-Piqué, A.; Maass, F.; Gmitterová, K.; Varges, D. & Lingor, P. et al.​ (2021) 
  Frontiers in Aging Neuroscience, 13.​ DOI: https://doi.org/10.3389/fnagi.2021.717930 
  ​Details  DOI 

• 2021 | Journal Article | 
  ​ ​TREM2 expression in the brain and biological fluids in prion diseases​
  Diaz-Lucena, D.; Kruse, N.; Thüne, K.; Schmitz, M.; Villar-Piqué, A.; da Cunha, J. E. G. & Hermann, P. et al.​ (2021) 
  Acta Neuropathologica, 141(6) pp. 841​-859​.​ DOI: https://doi.org/10.1007/s00401-021-02296-1 
  ​Details  DOI 

• 2021 | Journal Article | 
  ​ ​Diagnostic and prognostic value of plasma neurofilament light and total-tau in sporadic Creutzfeldt-Jakob disease​
  Zerr, I.; Villar-Piqué, A.; Hermann, P.; Schmitz, M.; Varges, D.; Ferrer, I. & Riggert, J. et al.​ (2021) 
  Alzheimer's Research & Therapy, 13(1) art. 86​.​ DOI: https://doi.org/10.1186/s13195-021-00815-6 
  ​Details  DOI 

• 2022 | Journal Article
  ​ ​Validation of Plasma and CSF Neurofilament Light Chain as an Early Marker for Sporadic Creutzfeldt-Jakob Disease​
  Schmitz, M.; Canaslan, S.; Espinosa, J. C.; Fernández-Borges, N.; Villar-Piqué, A.; Llorens, F. & Varges, D. et al.​ (2022) 
  Molecular Neurobiology,.​ DOI: https://doi.org/10.1007/s12035-022-02891-7 
  ​Details  DOI 

• 2022 | Journal Article
  ​ ​Diagnostic accuracy of cerebrospinal fluid biomarkers in genetic prion diseases​
  Schmitz, M.; Villar-Piqué, A.; Hermann, P.; Escaramís, G.; Calero, M.; Chen, C. & Kruse, N. et al.​ (2022) 
  Brain,.​ DOI: https://doi.org/10.1093/brain/awab350 
  ​Details  DOI 

• 2022 | Journal Article | Research Paper
  ​ ​Plasma Lipocalin 2 in Alzheimer’s disease: potential utility in the differential diagnosis and relationship with other biomarkers​
  Hermann, P.; Villar-Piqué, A.; Schmitz, M.; Schmidt, C.; Varges, D.; Goebel, S. & Bunck, T. et al.​ (2022) 
  Alzheimer's Research & Therapy, 14(1) art. 9​.​ DOI: https://doi.org/10.1186/s13195-021-00955-9 
  ​Details  DOI 

• 2023 | Journal Article | 
  ​ ​Comparative evaluation of clinical and cerebrospinal fluid biomarker characteristics in rapidly and non-rapidly progressive Alzheimer’s disease​
  Herden, J. M.; Hermann, P.; Schmidt, I.; Dittmar, K.; Canaslan, S.; Weglage, L. & Nuhn, S. et al.​ (2023) 
  Alzheimer's Research & Therapy, 15(1) art. 106​.​ DOI: https://doi.org/10.1186/s13195-023-01249-y 
  ​Details  DOI 

Researcher

Sort

Items per Page